Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 30 | 2023 | 209 | 10.670 |
Why?
|
| Pulmonary Fibrosis | 10 | 2023 | 108 | 5.020 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 20 | 2023 | 136 | 4.920 |
Why?
|
| Alveolitis, Extrinsic Allergic | 9 | 2022 | 32 | 2.700 |
Why?
|
| Mucin-5B | 3 | 2019 | 10 | 1.700 |
Why?
|
| Lung | 13 | 2022 | 1104 | 1.620 |
Why?
|
| Pyridones | 2 | 2020 | 41 | 1.400 |
Why?
|
| Connective Tissue Diseases | 8 | 2023 | 63 | 1.370 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2022 | 2446 | 1.310 |
Why?
|
| Indoles | 2 | 2020 | 317 | 1.220 |
Why?
|
| Idiopathic Interstitial Pneumonias | 4 | 2022 | 28 | 1.200 |
Why?
|
| Telomere | 4 | 2021 | 94 | 1.200 |
Why?
|
| Hospitalization | 4 | 2021 | 770 | 1.190 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1625 | 0.940 |
Why?
|
| Nitric Oxide | 2 | 2022 | 273 | 0.940 |
Why?
|
| Humans | 62 | 2023 | 81308 | 0.930 |
Why?
|
| Cohort Studies | 12 | 2023 | 2600 | 0.930 |
Why?
|
| Delayed Diagnosis | 2 | 2019 | 28 | 0.920 |
Why?
|
| Aged | 31 | 2023 | 17570 | 0.920 |
Why?
|
| Disease Progression | 10 | 2023 | 1436 | 0.920 |
Why?
|
| Mediastinum | 2 | 2019 | 46 | 0.920 |
Why?
|
| Autoimmunity | 4 | 2018 | 158 | 0.910 |
Why?
|
| Rheumatoid Factor | 1 | 2021 | 24 | 0.900 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 15 | 0.890 |
Why?
|
| Mediastinal Diseases | 1 | 2021 | 20 | 0.890 |
Why?
|
| African Americans | 2 | 2020 | 1079 | 0.880 |
Why?
|
| Intra-Abdominal Fat | 1 | 2021 | 30 | 0.870 |
Why?
|
| Friends | 1 | 2021 | 14 | 0.850 |
Why?
|
| Immunosuppressive Agents | 5 | 2019 | 986 | 0.820 |
Why?
|
| Fibrosis | 5 | 2022 | 191 | 0.810 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 154 | 0.800 |
Why?
|
| Radiography, Thoracic | 3 | 2019 | 317 | 0.800 |
Why?
|
| Autoimmune Diseases | 3 | 2017 | 235 | 0.780 |
Why?
|
| Hypertension, Pulmonary | 5 | 2022 | 322 | 0.780 |
Why?
|
| Racism | 1 | 2021 | 70 | 0.780 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2020 | 47 | 0.770 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 199 | 0.760 |
Why?
|
| Mortality | 1 | 2020 | 148 | 0.750 |
Why?
|
| Patient Compliance | 1 | 2020 | 223 | 0.710 |
Why?
|
| Lymph Nodes | 2 | 2019 | 515 | 0.690 |
Why?
|
| Pandemics | 2 | 2021 | 620 | 0.680 |
Why?
|
| Male | 34 | 2023 | 39770 | 0.670 |
Why?
|
| Prognosis | 9 | 2023 | 3549 | 0.660 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 259 | 0.650 |
Why?
|
| Betacoronavirus | 1 | 2020 | 245 | 0.640 |
Why?
|
| Retrospective Studies | 19 | 2023 | 7600 | 0.640 |
Why?
|
| Pathology, Clinical | 1 | 2017 | 32 | 0.640 |
Why?
|
| Female | 33 | 2023 | 42685 | 0.630 |
Why?
|
| Multiple Chronic Conditions | 1 | 2016 | 5 | 0.630 |
Why?
|
| Lung Transplantation | 3 | 2020 | 166 | 0.620 |
Why?
|
| Middle Aged | 25 | 2021 | 24127 | 0.590 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 302 | 0.560 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 286 | 0.560 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 141 | 0.550 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 813 | 0.540 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 97 | 0.520 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 244 | 0.520 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 126 | 0.510 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 630 | 0.480 |
Why?
|
| Aortic Valve Stenosis | 2 | 2011 | 116 | 0.470 |
Why?
|
| Risk Assessment | 6 | 2021 | 2180 | 0.440 |
Why?
|
| Biomarkers | 4 | 2021 | 1617 | 0.430 |
Why?
|
| Prevalence | 7 | 2021 | 1190 | 0.420 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 2193 | 0.410 |
Why?
|
| Survival Analysis | 4 | 2019 | 1521 | 0.400 |
Why?
|
| United States | 7 | 2021 | 6191 | 0.400 |
Why?
|
| Hypoxia | 1 | 2015 | 607 | 0.380 |
Why?
|
| Inflammation | 1 | 2015 | 845 | 0.380 |
Why?
|
| Quality of Life | 1 | 2016 | 1401 | 0.360 |
Why?
|
| Survival Rate | 4 | 2020 | 1820 | 0.350 |
Why?
|
| Echocardiography | 2 | 2022 | 866 | 0.330 |
Why?
|
| Cause of Death | 2 | 2019 | 273 | 0.330 |
Why?
|
| Registries | 5 | 2022 | 655 | 0.320 |
Why?
|
| Heart Failure | 1 | 2015 | 1099 | 0.300 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2101 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 918 | 0.290 |
Why?
|
| Phenotype | 3 | 2020 | 2292 | 0.250 |
Why?
|
| Adult | 8 | 2023 | 24771 | 0.250 |
Why?
|
| Telomerase | 2 | 2020 | 53 | 0.250 |
Why?
|
| Biopsy | 4 | 2021 | 1125 | 0.240 |
Why?
|
| Leukocytes | 2 | 2021 | 192 | 0.240 |
Why?
|
| Age Factors | 3 | 2020 | 1803 | 0.240 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1698 | 0.240 |
Why?
|
| Minority Groups | 1 | 2023 | 119 | 0.220 |
Why?
|
| Risk Factors | 3 | 2021 | 5177 | 0.220 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 953 | 0.220 |
Why?
|
| Inhalation Exposure | 1 | 2021 | 29 | 0.210 |
Why?
|
| Health Services | 1 | 2021 | 55 | 0.210 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 86 | 0.210 |
Why?
|
| Occupational Health | 1 | 2021 | 32 | 0.210 |
Why?
|
| Hematology | 1 | 2020 | 27 | 0.210 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 106 | 0.200 |
Why?
|
| Vital Capacity | 4 | 2022 | 61 | 0.200 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 71 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1499 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2021 | 76 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 377 | 0.200 |
Why?
|
| Telomere-Binding Proteins | 1 | 2019 | 14 | 0.200 |
Why?
|
| Myeloblastin | 1 | 2019 | 5 | 0.190 |
Why?
|
| Mutation | 3 | 2020 | 3791 | 0.190 |
Why?
|
| Peroxidase | 1 | 2019 | 53 | 0.190 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2019 | 20 | 0.190 |
Why?
|
| Respiratory Function Tests | 4 | 2022 | 132 | 0.190 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 308 | 0.180 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 73 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 329 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 968 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 370 | 0.170 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 58 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2021 | 333 | 0.170 |
Why?
|
| Propensity Score | 1 | 2018 | 136 | 0.170 |
Why?
|
| Bronchiectasis | 1 | 2017 | 12 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2021 | 388 | 0.170 |
Why?
|
| Acetylcysteine | 1 | 2018 | 69 | 0.170 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2017 | 19 | 0.160 |
Why?
|
| Time Factors | 3 | 2021 | 5161 | 0.160 |
Why?
|
| Interleukin-5 | 1 | 2017 | 36 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 1535 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2023 | 3955 | 0.160 |
Why?
|
| Sex Factors | 1 | 2020 | 1025 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2017 | 944 | 0.160 |
Why?
|
| Transcriptome | 1 | 2021 | 527 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2019 | 307 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2017 | 62 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2017 | 354 | 0.150 |
Why?
|
| Disease Management | 2 | 2016 | 324 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 79 | 0.150 |
Why?
|
| Azathioprine | 1 | 2016 | 122 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 557 | 0.140 |
Why?
|
| Hypoventilation | 1 | 2015 | 6 | 0.140 |
Why?
|
| Chemotactic Factors | 1 | 2015 | 15 | 0.140 |
Why?
|
| STAT6 Transcription Factor | 1 | 2015 | 27 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2018 | 664 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 924 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 464 | 0.140 |
Why?
|
| Antigens | 1 | 2016 | 240 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 159 | 0.130 |
Why?
|
| Logistic Models | 1 | 2018 | 1117 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 347 | 0.130 |
Why?
|
| Genomics | 1 | 2019 | 644 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 158 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 250 | 0.130 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 313 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 107 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 278 | 0.130 |
Why?
|
| Genotype | 1 | 2019 | 1810 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2016 | 275 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 258 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2015 | 253 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6244 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2015 | 406 | 0.110 |
Why?
|
| Child | 1 | 2023 | 6639 | 0.110 |
Why?
|
| Autopsy | 2 | 2021 | 99 | 0.110 |
Why?
|
| Cytokines | 1 | 2015 | 755 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1035 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7589 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2020 | 3167 | 0.090 |
Why?
|
| Antibodies, Antinuclear | 2 | 2018 | 82 | 0.090 |
Why?
|
| Obesity | 1 | 2015 | 927 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 376 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 830 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 2160 | 0.070 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2011 | 497 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1747 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 849 | 0.070 |
Why?
|
| Lung Volume Measurements | 1 | 2022 | 19 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 1947 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2022 | 61 | 0.060 |
Why?
|
| Canada | 1 | 2022 | 195 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2595 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 305 | 0.050 |
Why?
|
| Biology | 1 | 2020 | 43 | 0.050 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2020 | 8 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2020 | 9 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2020 | 20 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2020 | 7 | 0.050 |
Why?
|
| Chemokine CXCL13 | 1 | 2020 | 15 | 0.050 |
Why?
|
| Exoribonucleases | 1 | 2019 | 8 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 55 | 0.050 |
Why?
|
| Spindle Apparatus | 1 | 2020 | 63 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 349 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 235 | 0.050 |
Why?
|
| Vasculitis | 1 | 2019 | 38 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 58 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 323 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2019 | 63 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2021 | 243 | 0.050 |
Why?
|
| Animals | 2 | 2017 | 25878 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 179 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 451 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2021 | 295 | 0.040 |
Why?
|
| Bleomycin | 1 | 2017 | 97 | 0.040 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 23 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 100 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1725 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2016 | 85 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1419 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2017 | 234 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2017 | 152 | 0.040 |
Why?
|
| RNA | 1 | 2019 | 522 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 394 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 285 | 0.040 |
Why?
|
| Observer Variation | 1 | 2017 | 590 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 1285 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 683 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 460 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 430 | 0.030 |
Why?
|
| Chicago | 1 | 2017 | 1340 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1910 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1343 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2798 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2187 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3072 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1891 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5754 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 10870 | 0.020 |
Why?
|